[{"Assets_0_Q3_USD":38050000.0,"CommonStockSharesOutstanding_0_Q3_shares":9713042.0,"NetIncomeLoss_1_Q3_USD":-7644000.0,"NetIncomeLoss_3_Q3_USD":-14401000.0,"StockholdersEquity_0_Q3_USD":34849000.0,"Ticker":"KALV","CIK":"1348911","name":"KALVISTA PHARMACEUTICALS, INC.","OfficialName":"KalVista Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170131","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339433230.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170316"}]